EYLEA

Formula & Concentration

EYLEA HD- aflibercept injection, solution

Manufacturer

Regeneron Healthcare Solutions Inc.

Indications

EYLEA HD is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with:

• Neovascular (Wet) Age-Related Macular Degeneration (nAMD)
• Diabetic Macular Edema (DME)
• Diabetic Retinopathy (DR)

Product Options

Package Size

NDC #

Presentation

2 mg

61755-0005-01

Syringe

8 mg

61755-0050-01

Vial

Shelf Life and Storage

Refrigerate EYLEA at 2°C to 8°C (36°F to 46°F). Do not freeze. Do not use beyond the date stamped on the carton and container label. Store in the original carton until time of use to protect from light. Do not open sealed blister tray until time of use.